Cresco Labs Inc. ( CL.CN) - Key Metrics
CL.CN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | CA$0.48 | -CA$0.27 | CA$0.08 | CA$0.05 |
| 2025Q3 | CA$0.46 | -CA$0.05 | CA$0.02 | CA$0 |
| 2025Q2 | CA$0.46 | -CA$0.05 | CA$0.02 | -CA$0.01 |
| 2025Q1 | CA$0.47 | -CA$0.04 | CA$0.09 | CA$0.07 |
| 2024Q4 | CA$0.50 | -CA$0.01 | CA$0.08 | CA$0.07 |
CL.CN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -1.16 |
| 2025Q3 | ? | -6.92 |
| 2025Q2 | ? | -2.79 |
| 2025Q1 | ? | -4.40 |
| 2024Q4 | ? | -18.24 |
CL.CN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 4.47% | ? |
| 2025Q3 | -0.30% | ? |
| 2025Q2 | -2.45% | ? |
| 2025Q1 | 9.23% | ? |
| 2024Q4 | 8.15% | ? |
CL.CN
Price: CA$1.24
52 week price:
Earnings Per Share: -0.21 CAD
P/E Ratio: -6
Exchange: CNQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 429.0 million